Latest news
Energenesis Biomedical partners with Taiwan Tanabe Seiyaku to develop topical drug for diabetic foot ulcers - BioSpectrum AsiaBioSpectrum Asia · Fri, 07 Aug 2026 19:20:30 GMTEnergenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for ENERGI-F703DFU - PR NewswirePR Newswire · Thu, 06 Aug 2026 23:00:00 GMTEnterprise value to EBITDA forward of Energenesis Biomedical Co., Ltd. – TWSE:6657 - TradingViewTradingView · Sun, 02 Aug 2026 21:58:52 GMT